Oct 12 (Reuters) - Acura Pharmaceuticals Inc ACUR.PK :
* ACURA PHARMACEUTICALS INC - ON OCTOBER 11, RECEIVED A
$250,000
LOAN FROM ABUSE DETERRENT PHARMA, LLC
* ACURA PHARMACEUTICALS INC - FUNDING PROVIDED BY AD PHARMA
WILL
BE USED FOR OPERATIONS THROUGH END OF LATE-NOVEMBER 2023
* ACURA PHARMACEUTICALS INC - THERE CAN BE NO ASSURANCE WE
WILL BE
SUCCESSFUL IN RECEIVING ADDITIONAL FINANCING
* ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF
ADDITIONAL
FINANCING BY LATE-NOVEMBER 2023, WILL BE REQUIRED TO SCALE BACK
OR TERMINATE OPERATIONS
* ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF FINANCING
BY
LATE-NOVEMBER 2023, WILL BE REQUIRED TO SEEK PROTECTION UNDER
APPLICABLE BANKRUPTCY LAWS
Source text for Eikon: ID:
Further company coverage: ACUR.PK